WST1 - Clinical and Economic Data Supporting the Use of Janssen Long-Acting Injectable Antipsychotics in Adult Patients With Schizophrenia

Monday, May 1, 2023

12:00 PM – 1:00 PM

Location: South Exhibit Hall HJK, Level 2, LACC

Sponsored By:

Exhibitor Symposia - Presenter(s)

Christoph U. Correll, MD

Professor of Psychiatry & Professor and Chair of the Department of Child and Adolescent Psychiatry
The Zucker School of Medicine at Hofstra/Northwell & Charité University Medicine

During the 1-hour theater exhibit spotlight, Dr. Correll will review clinical data supporting the use of Janssen Iong-acting injectable (LAI) antipsychotics (INVEGA SUSTENNA®; INVEGA TRINZA®; INVEGA HAFYERA®) for the treatment of schizophrenia in adult patients and discuss the economic impact following treatment with INVEGA SUSTENNA® and INVEGA TRINZA® from real-world data.